Skip to main content

Table 1 Thresholds for defining response levels

From: Applying the win ratio method in clinical trials of orphan drugs: an analysis of data from the COMET trial of avalglucosidase alfa in patients with late-onset Pompe disease

Change from baseline at week 49 in

Meaningful improvement

No meaningful improvement or decline

Meaningful decline

FVC, % predicted

Increase ≥ 4%

Increase or decrease < 4%

Decrease ≥ 4%

6MWT

Increase ≥ 39 m

Increase or decrease < 39 m

Decrease ≥ 39 m

  1. 6MWT 6-min walk test, CI confidence interval, FVC forced vital capacity